Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 14, Issue 1, Pages -
Publisher
EMBO
Online
2021-11-02
DOI
10.15252/emmm.202114073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
- (2020) Aviad Ben-Shmuel et al. Frontiers in Immunology
- The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
- (2019) Fernando Souza-Fonseca-Guimaraes et al. TRENDS IN IMMUNOLOGY
- Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
- (2019) Shweta Joshi et al. Journal of Oncology
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- NK cells to cure cancer
- (2019) Clara Di Vito et al. SEMINARS IN IMMUNOLOGY
- The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy
- (2019) Richard D. Paucek et al. TRENDS IN IMMUNOLOGY
- Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
- (2019) Laurent Gauthier et al. CELL
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
- (2019) Jayesh A. Kulkarni et al. ACCOUNTS OF CHEMICAL RESEARCH
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
- (2019) Haoyu Sun et al. Frontiers in Immunology
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- Strategies to enhance NK cell function for the treatment of tumors and infections
- (2018) Jacquelyn Freund-Brown et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP‐1
- (2018) Omri Matalon et al. EMBO JOURNAL
- Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells
- (2018) Suresh Bugide et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Natural killer cells in inflammation and autoimmunity
- (2018) Beatrice Zitti et al. CYTOKINE & GROWTH FACTOR REVIEWS
- FDA approves patisiran to treat hereditary transthyretin amyloidosis
- (2018) Heather Wood Nature Reviews Neurology
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- Natural Killer Cells: Angels and Devils for Immunotherapy
- (2017) Beatriz Martín-Antonio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
- (2017) Robert Torphy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation
- (2017) Josefa A. Rodríguez Oncology Letters
- Clinical Applications of Immunotherapy Combination Methods and New Opportunities for the Future
- (2017) Ece Esin Biomed Research International
- Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell Subset
- (2017) Mathieu Amand et al. Frontiers in Immunology
- Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity
- (2017) Yonat Shemer-Avni et al. Frontiers in Immunology
- Combination immunotherapy: a road map
- (2017) Patrick A. Ott et al. Journal for ImmunoTherapy of Cancer
- Targeting protein function: the expanding toolkit for conditional disruption
- (2016) A. E. Campbell et al. BIOCHEMICAL JOURNAL
- Immune targets and neoantigens for cancer immunotherapy and precision medicine
- (2016) Rong-Fu Wang et al. CELL RESEARCH
- Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy
- (2016) Alessandra Zingoni et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Suppressing the killer instinct
- (2016) Kerry S. Campbell Science Signaling
- Dephosphorylation of the adaptor LAT and phospholipase C–γ by SHP-1 inhibits natural killer cell cytotoxicity
- (2016) Omri Matalon et al. Science Signaling
- Suppressing the killer instinct
- (2016) Kerry S. Campbell Science Signaling
- Dephosphorylation of the adaptor LAT and phospholipase C–γ by SHP-1 inhibits natural killer cell cytotoxicity
- (2016) Omri Matalon et al. Science Signaling
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Practical NK cell phenotyping and variability in healthy adults
- (2015) Laura S. Angelo et al. IMMUNOLOGIC RESEARCH
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
- (2015) Rami Yossef et al. PLoS One
- Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
- (2014) James O.J. Davies et al. CYTOTHERAPY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Application of liposomes in medicine and drug delivery
- (2014) Hadis Daraee et al. Artificial Cells Nanomedicine and Biotechnology
- Cross-Talks between Natural Killer Cells and Distinct Subsets of Dendritic Cells
- (2014) Guido Ferlazzo et al. Frontiers in Immunology
- A review of the current status of siRNA nanomedicines in the treatment of cancer
- (2013) Pauline Resnier et al. BIOMATERIALS
- A daunting task: manipulating leukocyte function with RNAi
- (2013) Dan Peer IMMUNOLOGICAL REVIEWS
- RNAi-based nanomedicines for targeted personalized therapy
- (2012) Ala Daka et al. ADVANCED DRUG DELIVERY REVIEWS
- NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
- (2012) Ariane Thielens et al. CURRENT OPINION IN IMMUNOLOGY
- Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1
- (2012) A. Glasner et al. JOURNAL OF IMMUNOLOGY
- Hyaluronan-grafted particle clusters loaded with Mitomycin C as selective nanovectors for primary head and neck cancers
- (2011) Gideon Bachar et al. BIOMATERIALS
- The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
- (2011) Elizabeth A. Vasievich et al. MOLECULAR PHARMACEUTICS
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- SHP-2 Expression Negatively Regulates NK Cell Function
- (2009) A. K. Purdy et al. JOURNAL OF IMMUNOLOGY
- Natural killer cell-based immunotherapy in cancer: current insights and future prospects
- (2009) T. Sutlu et al. JOURNAL OF INTERNAL MEDICINE
- Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
- (2009) Aimee L. Jackson et al. NATURE REVIEWS DRUG DISCOVERY
- Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
- (2008) J DEVINCENZO et al. ANTIVIRAL RESEARCH
- Inhibitory Receptor Signaling via Tyrosine Phosphorylation of the Adaptor Crk
- (2008) Mary E. Peterson et al. IMMUNITY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target
- (2008) D. Peer et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now